HBM4EU Occupational Biomonitoring Study on e-Waste-Study Protocol.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
09 12 2021
Historique:
received: 01 11 2021
revised: 27 11 2021
accepted: 01 12 2021
entrez: 24 12 2021
pubmed: 25 12 2021
medline: 1 1 2022
Statut: epublish

Résumé

Workers involved in the processing of electronic waste (e-waste) are potentially exposed to toxic chemicals. If exposure occurs, this may result in uptake and potential adverse health effects. Thus, exposure surveillance is an important requirement for health risk management and prevention of occupational disease. Human biomonitoring by measurement of specific biomarkers in body fluids is considered as an effective method of exposure surveillance. The aim of this study is to investigate the internal exposure of workers processing e-waste using a human biomonitoring approach, which will stimulate improved work practices and contribute to raising awareness of potential hazards. This exploratory study in occupational exposures in e-waste processing is part of the European Human Biomonitoring Initiative (HBM4EU). Here we present a study protocol using a cross sectional survey design to study worker's exposures and compare these to the exposure of subjects preferably employed in the same company but with no known exposure to industrial recycling of e-waste. The present study protocol will be applied in six to eight European countries to ensure standardised data collection. The target population size is 300 exposed and 150 controls. Biomarkers of exposure for the following chemicals will be used: chromium, cadmium and lead in blood and urine; brominated flame retardants and polychlorobiphenyls in blood; mercury, organophosphate flame retardants and phthalates in urine, and chromium, cadmium, lead and mercury in hair. In addition, the following effect biomarkers will be studied: micronuclei, epigenetic, oxidative stress, inflammatory markers and telomere length in blood and metabolomics in urine. Occupational hygiene sampling methods (airborne and settled dust, silicon wristbands and handwipes) and contextual information will be collected to facilitate the interpretation of the biomarker results and discuss exposure mitigating interventions to further reduce exposures if needed. This study protocol can be adapted to future European-wide occupational studies.

Identifiants

pubmed: 34948598
pii: ijerph182412987
doi: 10.3390/ijerph182412987
pmc: PMC8701897
pii:
doi:

Substances chimiques

Dust 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Environ Sci Technol. 2012 Oct 16;46(20):10861-7
pubmed: 22998401
Toxicol Appl Pharmacol. 1998 May;150(1):146-53
pubmed: 9630463
Int Arch Occup Environ Health. 2021 Jul;94(5):935-944
pubmed: 33486553
Environ Int. 2014 Oct;71:158-63
pubmed: 25033099
Int J Environ Res Public Health. 2019 May 21;16(10):
pubmed: 31117209
J Clin Invest. 1976 Aug;58(2):260-70
pubmed: 783195
Lancet Glob Health. 2013 Aug;1(2):e70
pubmed: 25104155
Int J Hyg Environ Health. 2021 May;234:113725
pubmed: 33714856
Environ Int. 2016 Oct;95:157-66
pubmed: 27568575
Int J Environ Res Public Health. 2020 Aug 13;17(16):
pubmed: 32823696
Environ Int. 2019 Jul;128:244-253
pubmed: 31059919
Environ Int. 2019 Dec;133(Pt A):105143
pubmed: 31630067
Environ Toxicol Chem. 2019 May;38(5):1132-1141
pubmed: 30821838
J Hazard Mater. 2021 Jul 5;413:125322
pubmed: 33588336
Environ Res. 2020 Aug;187:109531
pubmed: 32454306
J Toxicol Environ Health. 1996 Dec 6;49(5):453-61
pubmed: 8968407
Int Arch Occup Environ Health. 1997;70(4):237-42
pubmed: 9342623
Ann Occup Hyg. 2016 Oct;60(8):991-1008
pubmed: 27358294
Environ Res. 2019 Oct;177:108583
pubmed: 31330491
Environ Res. 2022 Mar;204(Pt A):111984
pubmed: 34492275
Lancet Glob Health. 2013 Dec;1(6):e350-61
pubmed: 25104600
Waste Manag. 2009 Oct;29(10):2700-6
pubmed: 19581078
Int J Hyg Environ Health. 2021 May;234:113740
pubmed: 33774419
Environ Sci Technol. 2006 Oct 15;40(20):6247-54
pubmed: 17120549
Environ Int. 2014 Dec;73:243-51
pubmed: 25300751
Curr Environ Health Rep. 2019 Dec;6(4):256-268
pubmed: 31734812
Environ Health Perspect. 1999 Aug;107(8):643-8
pubmed: 10417362
Rapid Commun Mass Spectrom. 2009 Aug 30;23(16):2467-75
pubmed: 19603467
J Environ Manage. 2011 Mar;92(3):392-9
pubmed: 21084150
Int Arch Occup Environ Health. 1986;57(4):249-57
pubmed: 3519469
Int J Hyg Environ Health. 2017 Mar;220(2 Pt A):94-97
pubmed: 28284775
Environ Res. 2021 Nov;202:111705
pubmed: 34297934
Environ Int. 2019 Aug;129:95-104
pubmed: 31125732
Am J Ind Med. 1989;16(5):485-92
pubmed: 2686406
Sci Total Environ. 2019 Jul 1;672:314-323
pubmed: 30959298
Toxicol Lett. 2008 May 30;178(3):185-90
pubmed: 18455331
J Toxicol Sci. 2012 Feb;37(1):123-30
pubmed: 22293416
Scand J Work Environ Health. 1985 Oct;11(5):381-7
pubmed: 4071004
Environ Health Perspect. 2016 May;124(5):550-5
pubmed: 26418733
Waste Manag Res. 2013 Feb;31(2):130-40
pubmed: 23129606
Ann Occup Hyg. 2011 Jul;55(6):658-65
pubmed: 21742626
Environ Int. 2020 Nov;144:106041
pubmed: 32822924
Environ Res. 2021 Mar;194:110728
pubmed: 33444608
Anal Bioanal Chem. 2017 Jul;409(19):4507-4515
pubmed: 28593372

Auteurs

Paul T J Scheepers (PTJ)

Radboud Institute for Health Sciences, Radboudumc, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.

Radu Corneliu Duca (RC)

Department of Health Protection, Laboratoire National de Santé (LNS), 1 rue Louis Rech, 3555 Luxembourg, Luxembourg.
Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), Kapucijnenvoer 35, 3000 Leuven, Belgium.

Karen S Galea (KS)

Institute of Occupational Medicine (IOM), Edinburgh EH14 4AP, UK.

Lode Godderis (L)

Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), Kapucijnenvoer 35, 3000 Leuven, Belgium.
IDEWE, External Service for Prevention and Protection at Work, Interleuvenlaan 58, 3001 Heverlee, Belgium.

Emilie Hardy (E)

Department of Health Protection, Laboratoire National de Santé (LNS), 1 rue Louis Rech, 3555 Luxembourg, Luxembourg.

Lisbeth E Knudsen (LE)

Department of Public Health, University of Copenhagen, Øster Farimagsgade 5, 1353 Copenhagen, Denmark.

Elizabeth Leese (E)

Health & Safety Executive, Buxton SK17 9JN, UK.

Henriqueta Louro (H)

INSA, National Institute of Health Dr. Ricardo Jorge, Department of Human Genetics, Av. Padre Cruz, 1600-609 Lisbon, Portugal.
Centre for Toxicogenomics and Human Health, NOVA Medical School, Universidade NOVA de Lisboa, Campo dos Mártires da Pátria 130, 1169-056 Lisbon, Portugal.

Selma Mahiout (S)

Finnish Institute of Occupational Health, Topeliuksenkatu 41 b, 00250 Helsinki, Finland.

Sophie Ndaw (S)

INRS, French National Research and Safety Institute, 54500 Vandœuvre-lès-Nancy, France.

Katrien Poels (K)

Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), Kapucijnenvoer 35, 3000 Leuven, Belgium.

Simo P Porras (SP)

Finnish Institute of Occupational Health, Topeliuksenkatu 41 b, 00250 Helsinki, Finland.

Maria J Silva (MJ)

INSA, National Institute of Health Dr. Ricardo Jorge, Department of Human Genetics, Av. Padre Cruz, 1600-609 Lisbon, Portugal.
Centre for Toxicogenomics and Human Health, NOVA Medical School, Universidade NOVA de Lisboa, Campo dos Mártires da Pátria 130, 1169-056 Lisbon, Portugal.

Ana Maria Tavares (AM)

INSA, National Institute of Health Dr. Ricardo Jorge, Department of Human Genetics, Av. Padre Cruz, 1600-609 Lisbon, Portugal.

Jelle Verdonck (J)

Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), Kapucijnenvoer 35, 3000 Leuven, Belgium.

Susana Viegas (S)

NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, 1600-560 Lisbon, Portugal.
Comprehensive Health Research Center (CHRC), 1600-560 Lisbon, Portugal.

Tiina Santonen (T)

Finnish Institute of Occupational Health, Topeliuksenkatu 41 b, 00250 Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH